It Floats -- But is it Safe?

  • by: |
  • 05/27/2008
One of the most potent products available to battle public health issues -- such as the flu -- isn't completely safe.

The product is Ivory Soap -- and it's only 99 and 44/100th% pure. Should it be taken off the market?

Silly? Not when you consider that the current debate over drug safety is being hijacked by the Panjandrums of the Precautionary Principle. What we need is a debate on smart safety.

Have a look at this new op-ed in The Journal of Life Sciences, "A Balancing Act:."

Here's the link:

www.tjols.com/article-662.html

And here's a taste:

"Our system of drug regulation involves a careful balancing of drug benefits and risks based on the best possible scientific information that can be discovered about a new drug’s safety profile. Reform is needed, but careful and considered reform that advances our understanding of safety in the context the individual patient – not hasty measures that grab headlines and do harm to the public health by slowing down the availability of new and better medicines.
 
Pharmaceutical companies should seek out, monitor and report adverse events in new ways, especially for drugs that are widely prescribed off-label. But hasty regulatory concepts that allow dictatorial shutoffs and demonize the pharmaceutical industry are just as likely to slow the pace of medical progress.
 
We must work for reform that makes drugs safer, but avoid those that might unintentionally slow down the flow of new medicines, or worse, discourage the creation of them altogether. Safety is always an issue, but patients with life threatening diseases also have a right to timely access to advances in medicine."


CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog